Nature Communications (Aug 2021)

Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors

  • Katie L. Kunze,
  • Patrick W. Johnson,
  • Noud van Helmond,
  • Jonathon W. Senefeld,
  • Molly M. Petersen,
  • Stephen A. Klassen,
  • Chad C. Wiggins,
  • Allan M. Klompas,
  • Katelyn A. Bruno,
  • John R. Mills,
  • Elitza S. Theel,
  • Matthew R. Buras,
  • Michael A. Golafshar,
  • Matthew A. Sexton,
  • Juan C. Diaz Soto,
  • Sarah E. Baker,
  • John R. A. Shepherd,
  • Nicole C. Verdun,
  • Peter Marks,
  • Nigel S. Paneth,
  • DeLisa Fairweather,
  • R. Scott Wright,
  • Camille M. van Buskirk,
  • Jeffrey L. Winters,
  • James R. Stubbs,
  • Katherine A. Senese,
  • Michaela C. Pletsch,
  • Zachary A. Buchholtz,
  • Robert F. Rea,
  • Vitaly Herasevich,
  • Emily R. Whelan,
  • Andrew J. Clayburn,
  • Kathryn F. Larson,
  • Juan G. Ripoll,
  • Kylie J. Andersen,
  • Elizabeth R. Lesser,
  • Matthew N. P. Vogt,
  • Joshua J. Dennis,
  • Riley J. Regimbal,
  • Philippe R. Bauer,
  • Janis E. Blair,
  • Arturo Casadevall,
  • Rickey E. Carter,
  • Michael J. Joyner

DOI
https://doi.org/10.1038/s41467-021-25113-5
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 6

Abstract

Read online

Regional differences in SARS-CoV-2 variants may affect treatment outcome. Here, the authors show that near-sourced convalescent plasma has higher efficacy, as defined by death within 30 days of transfusion, than plasma sourced more than 150 miles away.